Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults
Authors:
- Hien PhamHPHien Pham
- Cassianne Robinson-CohenCRCassianne Robinson-Cohen
- Mary L. BiggsMBMary L. Biggs
- Joachim H. IxJIJoachim H. Ix
- Kenneth J. MukamalKMKenneth J. Mukamal
- Linda F. FriedLFLinda F. Fried
- Bryan KestenbaumBKBryan Kestenbaum
- David S. SiscovickDSDavid S. Siscovick
- Ian H. de BoerIBIan H. de Boer
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 7 (4) , 588-594
Abstract
Summary: Background and objectives: Insulin resistance is a complication of advanced CKD. Insulin resistance is less well characterized in earlier stages of CKD. The response of the pancreatic β cell, effects on glucose tolerance, and risk of diabetes are not clear. Design, setting, participants, & measurements: The Cardiovascular Health Study included 4680 adults without baseline diabetes. The Chronic Kidney Disease Epidemiology Collaboration creatinine equation was used to obtain the estimated GFR (eGFR). Insulin resistance was evaluated as fasting insulin concentration. The insulin sensitivity index, β cell function, and glucose tolerance were assessed by oral glucose tolerance testing. Incident diabetes was defined as fasting glucose ≥126 mg/dl, nonfasting glucose ≥200 mg/dl, or use of glucose-lowering medications. Results: Mean age was 72.5 years (range, 65–98 years). Mean eGFR was 72.2 (SD 17.1) ml/min per 1.73 m2. After adjustment, each 10 ml/min per 1.73 m2 lower eGFR was associated with a 2.2% higher fasting insulin concentration (95% confidence interval [CI], 1.4%, 2.9%; PP=0.04). Surprisingly, eGFR was associated with an augmented β cell function index (PP=0.002), and decreased risk of glucose intolerance (P=0.006). Over a median 12 years’ follow-up, 437 participants (9.3%) developed diabetes. eGFR was not associated with the risk of incident diabetes. Conclusions: Among older adults, lower eGFR was associated with insulin resistance. However, with lower eGFR, β cell function was appropriately augmented and risks of impaired glucose tolerance and incident diabetes were not increased.Keywords
This publication has 44 references indexed in Scilit:
- Serum cystatin C and the incidence of type 2 diabetes mellitusDiabetologia, 2011
- Correlates of insulin resistance in older individuals with and without kidney diseaseNephrology Dialysis Transplantation, 2011
- Reduced Time Points to Calculate the Composite IndexDiabetes Care, 2010
- Lifestyle Risk Factors and New-Onset Diabetes Mellitus in Older AdultsArchives of internal medicine (1960), 2009
- Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose LevelsDiabetes Care, 2009
- Vitamin D and glucose metabolism in chronic kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2008
- Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based CohortDiabetes Care, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolismMolecular Genetics and Metabolism, 2007
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005